FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Haralabos Kalofonos

Research Profile

Procedures

Antineoplastic Combined Chemotherapy Protocols

Disorders

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

Greece

Co-author Network

Publications

TOP 3
Andreas A Argyriou; C Briani; J Bruna; M Campagnolo; G Cavaletti; M Cazzaniga; D Cortinovis; S Lonardi; C Santos; R Velasco; P Alberti; Haralabos P Kalofonos
Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study.
Andreas A Argyriou; Francesca Bergamo; Chiara Briani; Jordi Bruna; Marta Campagnolo; Guido Cavaletti; Marina Cazzaniga; Diego Cortinovis; Konstantinos Papadimitriou; Cristina Santos; Roser Velasco; Paola Alberti; Haralabos P Kalofonos
Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer.
Marta Lucchetta; Roser Velasco; Sara Lonardi; Paola Alberti; Andreas A Argyriou; Francesca Bergamo; Chiara Briani; Jordi Bruna; Guido Cavaletti; Marina Cazzaniga; Diego Cortinovis; Haralabos P Kalofonos
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Haralabos Kalofonos (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Andreas A Argyriou; C Briani; J Bruna; M Campagnolo; G Cavaletti; M Cazzaniga; D Cortinovis; S Lonardi; C Santos; R Velasco; P Alberti; Haralabos P Kalofonos
Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2013;20(5):788-94.
2013: Andreas A Argyriou; Francesca Bergamo; Chiara Briani; Jordi Bruna; Marta Campagnolo; Guido Cavaletti; Marina Cazzaniga; Diego Cortinovis; Konstantinos Papadimitriou; Cristina Santos; Roser Velasco; Paola Alberti; Haralabos P Kalofonos
Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer.
Cancer 2013;119(2):438-44.
2012: Marta Lucchetta; Roser Velasco; Sara Lonardi; Paola Alberti; Andreas A Argyriou; Francesca Bergamo; Chiara Briani; Jordi Bruna; Guido Cavaletti; Marina Cazzaniga; Diego Cortinovis; Haralabos P Kalofonos
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer.
Cancer chemotherapy and pharmacology 2012;70(6):899-902.
2012: Angelos Koutras; Dionysia Lymperatou; Ioannis Starakis; Haralabos P Kalofonos
Angiogenesis as a therapeutic target in breast cancer.
Mini reviews in medicinal chemistry 2012;12(12):1230-8.
2012: Anastasia E Kottorou; Theodore Petsas; Chrisoula D Scopa; Athanasios C Tsamandas; Anna G Antonacopoulou; Fotinos-Ioannis D Dimitrakopoulos; Haralabos P Kalofonos
Altered expression of NFY-C and RORA in colorectal adenocarcinomas.
Acta histochemica 2012;114(6):553-61.
2012: Fotinos-Ioannis D Dimitrakopoulos; Dimitrios Dougenis; Anna G Antonacopoulou; Anastasia Kottorou; Nikolaos D Panagopoulos; Helen Papadaki; Chrisoula D Scopa; Helen Vlotinou; Haralabos P Kalofonos
NSCLC and the alternative pathway of NF-κB: uncovering an unknown relation.
Virchows Archiv : an international journal of pathology 2012;460(5):515-23.
2012: Helen Gogas; Haralabos P Kalofonos; Charisios Karanikiotis; Maria Karina; Paris Kosmidis; Christos Markopoulos; Christos Papadimitriou; Pavlos Papakostas; Dimitrios Pectasides; Epaminondas Samantas; George P Stathopoulos; Eleni Timotheadou; Dimitrios Bafaloukos; Anna Batistatou; Mattheos Bobos; Evangelos Briasoulis; Christos Christodoulou; Urania Dafni; Meletios A Dimopoulos; Anastasia G Eleftheraki; George Fountzilas
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial.
Breast cancer research and treatment 2012;132(2):609-19.
2012: Dimitrios Vomvas; Stavroula Beratis; Gregoris Iconomou; Haralabos P Kalofonos; Dimitrios Kardamakis; Michalis Leotsinidis; Evanthia Soubasi; Konstantinos Assimakopoulos
Assessment of sexual function in patients with cancer undergoing radiotherapy--a single centre prospective study.
Anticancer research 2012;32(2):657-64.
2012: Dionysios J Papachristou; Uma N M Rao; Emilia Sklirou; Efstathia Giannopoulou; Vasileios Kontogeorgakos; Angeliki Korpetinou; Haralabos P Kalofonos
Prognostic significance of Dicer cellular levels in soft tissue sarcomas.
Cancer investigation 2012;30(2):172-9.
2012: Dimitrios Pectasides; Dimosthenis Skarlos; Ioannis Varthalitis; Gerasimos Aravantinos; Dimitrios Bafaloukos; Evangelos Bournakis; Athanassios Meletios Dimopoulos; Helen Fountzilas; Haralabos P Kalofonos; Konstantine T Kalogeras; Ippokratis Korantzis; Paris Kosmidis; Vassiliki Kotoula; Angelos Koutras; Pavlos Papakostas; George Papaxoinis; George Fountzilas
Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) study.
Oncology reports 2012;27(1):216-24.
2011: Andreas A Argyriou; Panagiotis Karanasios; Pantelis Kraniotis; Konstantinos Papadimitriou; Stavros Peroukides; Ekaterini Solomou; Haralabos P Kalofonos
Large cell neuroendocrine carcinoma of the lung metastatic to the shoulder joint, causing suprascapular nerve palsy.
Journal of pain and symptom management 2011;42(6):e1-3.
2011: Andreas A Argyriou; Guido Cavaletti; Paola Marmiroli; Haralabos P Kalofonos
Epothilone-induced peripheral neuropathy: a review of current knowledge.
Journal of pain and symptom management 2011;42(6):931-40.
2011: Vikas Sharma; Shinya Tanaka; Anna G Antonacopoulou; Vasiliki Bravou; Haralabos P Kalofonos; Alexios A Panoutsopoulos; Vasso Episkopou
Enhancement of TGF-β signaling responses by the E3 ubiquitin ligase Arkadia provides tumor suppression in colorectal cancer.
Cancer research 2011;71(20):6438-49.
2011: Dionysios J Papachristou; Helen Papadaki; Chrisoula D Scopa; Angeliki Korpetinou; Anna G Antonacopoulou; Efstathia Giannopoulou; Petros Grivas; Haralabos P Kalofonos
Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas.
Virchows Archiv : an international journal of pathology 2011;459(4):431-40.
2011: Anna G Antonacopoulou; Vasiliki Bravou; Fotinos-Ioannis Dimitrakopoulos; Konstantina Floratou; Anastasia Kottorou; Angelos Koutras; Stella Marousi; Chrisoula D Scopa; Michalis Stavropoulos; Haralabos P Kalofonos
The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival.
Cellular oncology (Dordrecht) 2011;34(4):381-91.
2011: Evangelia Razis; G Rigakos; Dimosthenis Skarlos; Gerasimos Aravantinos; Dimitrios Bafaloukos; Mattheos Bobos; Ioannis Efstratiou; A G Eleftheraki; Haralabos P Kalofonos; K T Kalogeras; Ioannis Kostopoulos; Vassiliki Kotoula; Pavlos Papakostas; Kitty Pavlakis; Dimitrios Pectasides; K Petraki; George Fountzilas
Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer.
Breast cancer research and treatment 2011;128(2):447-56.
2011: Stavros Peroukides; Thomas Makatsoris; Angelos Koutras; Athanassios C Tsamandas; Adimchi Onyenadum; Chryssoula Labropoulou-Karatza; Haralabos P Kalofonos
Lapatinib-induced hepatitis: a case report.
World journal of gastroenterology : WJG 2011;17(18):2349-52.
2011: Fotinos-Ioannis D Dimitrakopoulos; Helen Papadaki; Anna G Antonacopoulou; Anastasia Kottorou; Andreas D Gotsis; Chrisoula D Scopa; Haralabos P Kalofonos; Athanasia Mouzaki
Association of FOXP3 expression with non-small cell lung cancer.
Anticancer research 2011;31(5):1677-83.
2011: Andreas A Argyriou; Haralabos P Kalofonos
Vitamin E for preventing chemotherapy-induced peripheral neuropathy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(5):725-6; author reply 727-8.
2011: Paris A Kosmidis; George Fountzilas; A G Eleftheraki; Haralabos P Kalofonos; G Pentheroudakis; Dimosthenis Skarlos; Meletios A Dimopoulos; Dimitrios Bafaloukos; D Pectasides; Epaminondas Samantas; J Boukovinas; S Lambaki; N Katirtzoglou; C Bakogiannis; K N Syrigos
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(4):827-34.
2011: Anna G Antonacopoulou; Fotinos-Ioannis D Dimitrakopoulos; Anastasia E Kottorou; Angelos Koutras; Stella Marousi; Vasiliki Triantafyllia; Haralabos P Kalofonos
VEGF polymorphisms may be associated with susceptibility to colorectal cancer: a case-control study.
Cancer biomarkers : section A of Disease markers 2011;10(5):213-7.
2011: Spyros S Skandalis; Katalin Dobra; Haralabos P Kalofonos; Nikos Karamanos; Vassiliki T Labropoulou; Eleni Likaki-Karatza; Panagiota Ravazoula; Achilleas D Theocharis
Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas.
BMC cancer 2011;11():314.
2011: V T Labropoulou; Achilleas D Theocharis; A Symeonidis; Spyros S Skandalis; Nikos Karamanos; Haralabos P Kalofonos
Pathophysiology and pharmacological targeting of tumor-induced bone disease: current status and emerging therapeutic interventions.
Current medicinal chemistry 2011;18(11):1584-98.
2011: A K Koutras; Ioannis Starakis; U Kyriakopoulou; P Katsaounis; Athanasios Nikolakopoulos; Haralabos P Kalofonos
Targeted therapy in colorectal cancer: current status and future challenges.
Current medicinal chemistry 2011;18(11):1599-612.
2011: Maria Martinou; Efstathia Giannopoulou; Georgia Malatara; Andreas A Argyriou; Haralabos P Kalofonos; Dimitrios Kardamakis
Ionizing radiation affects epidermal growth factor receptor signalling and metalloproteinase secretion in glioma cells.
Cancer genomics & proteomics 2011;8(1):33-8.
2011: Christos A Papadimitriou; Pavlos Papakostas; Maria Karina; Lia Malettou; Meletios A Dimopoulos; George Pentheroudakis; Epaminondas Samantas; Aristotelis Bamias; Dimosthenis Miliaras; George Basdanis; Nikolaos Xiros; George Klouvas; Dimitrios Bafaloukos; Georgia Kafiri; Irene Papaspirou; Dimitrios Pectasides; Charisios Karanikiotis; Theofanis Economopoulos; Ioannis Efstratiou; Ippokratis Korantzis; Nikolaos Pisanidis; Thomas Makatsoris; Fotini Matsiakou; Gerasimos Aravantinos; Haralabos P Kalofonos; George Fountzilas
A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study.
BMC medicine 2011;9():10.
2010: Konstantinos Dimitropoulos; Efstathia Giannopoulou; Andreas A Argyriou; Vassiliki Zolota; Theodore Petsas; Ekaterini Tsiata; Haralabos P Kalofonos
The effects of anti-VEGFR and anti-EGFR agents on glioma cell migration through implication of growth factors with integrins.
Anticancer research 2010;30(12):4987-92.
2010: Haralabos P Kalofonos; Pavlos Papakostas; Thomas Makatsoris; Demetrios Papamichael; Georgia Vourli; Ioannis Xanthakis; Gerasimos Aravantinos; Christos Papadimitriou; George Pentheroudakis; Ioannis Varthalitis; George Samelis; Kostas N Syrigos; Nikolaos Xiros; Michalis Stavropoulos; Paris Kosmidis; Christos Christodoulou; Helen Linardou; Maria Skondra; Dimitrios Pectasides; Theofanis Economopoulos; George Fountzilas
Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer.
Anticancer research 2010;30(10):4325-33.
2010: Efstathia Giannopoulou; Konstantinos Dimitropoulos; Andreas A Argyriou; Angelos K Koutras; Fotinos Dimitrakopoulos; Haralabos P Kalofonos
An in vitro study, evaluating the effect of sunitinib and/or lapatinib on two glioma cell lines.
Investigational new drugs 2010;28(5):554-60.
2010: Anna G Antonacopoulou; Maria Palli; Stella Marousi; Fotinos-Ioannis Dimitrakopoulos; Urania Kyriakopoulou; Athanassios C Tsamandas; Chrisoula D Scopa; Athanasios G Papavassiliou; Haralabos P Kalofonos
Prion protein expression and the M129V polymorphism of the PRNP gene in patients with colorectal cancer.
Molecular carcinogenesis 2010;49(7):693-9.
2010: A G Antonacopoulou; Andreas A Argyriou; Chrisoula D Scopa; A Kottorou; Athina Kominea; S Peroukides; Haralabos P Kalofonos
Integrin beta-3 L33P: a new insight into the pathogenesis of chronic oxaliplatin-induced peripheral neuropathy?
European journal of neurology : the official journal of the European Federation of Neurological Societies 2010;17(7):963-8.
2010: Helen Gogas; Dimitrios Pectasides; Ioannis Kostopoulos; Evangelos Lianos; Dimosthenis Skarlos; George Papaxoinis; Mattheos Bobos; Haralabos P Kalofonos; Kalliopi Petraki; Kitty Pavlakis; Dimitrios Bafaloukos; George Fountzilas
Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology Group.
Clinical breast cancer 2010;10(3):230-7.
2010: Angelos K Koutras; George Fountzilas; Konstantine T Kalogeras; Ioannis Starakis; Gregoris Iconomou; Haralabos P Kalofonos
The upgraded role of HER3 and HER4 receptors in breast cancer.
Critical reviews in oncology/hematology 2010;74(2):73-8.
2010: Stavros Peroukides; Vasiliki Bravou; Athanasios Alexopoulos; John Varakis; Haralabos P Kalofonos; Helen Papadaki
Survivin overexpression in HCC and liver cirrhosis differentially correlates with p-STAT3 and E-cadherin.
Histology and histopathology 2010;25(3):299-307.
2010: Angelos K Koutras; George Fountzilas; Thomas Makatsoris; Stavros Peroukides; Haralabos P Kalofonos
Bevacizumab in the treatment of breast cancer.
Cancer treatment reviews 2010;36(1):75-82.
2010: Anna G Antonacopoulou; Konstantina Floratou; Vasiliki Bravou; Anastasia Kottorou; Fotinos-Ioannis Dimitrakopoulos; Stella Marousi; Michalis Stavropoulos; Angelos Koutras; Chrisoula D Scopa; Haralabos P Kalofonos
The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival.
Analytical cellular pathology (Amsterdam) 2010;33(5):177-89.
2010: Dimitrios Bafaloukos; Helena Linardou; Gerasimos Aravantinos; Christos Papadimitriou; Aristotelis Bamias; George Fountzilas; Haralabos P Kalofonos; Paris Kosmidis; Eleni Timotheadou; Thomas Makatsoris; Epaminondas Samantas; Evangelos Briasoulis; Christos Christodoulou; Pavlos Papakostas; Dimitrios Pectasides; Athanasios M Dimopoulos
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study.
BMC medicine 2010;8():3.
2009: Efstathia Giannopoulou; Anna Antonacopoulou; Panagiota Matsouka; Haralabos P Kalofonos
Autophagy: novel action of panitumumab in colon cancer.
Anticancer research 2009;29(12):5077-82.
2009: George Pentheroudakis; Konstantine T Kalogeras; Ralph M Wirtz; Irene Grimani; George Zografos; Helen Gogas; Udo Stropp; Dimitrios Pectasides; Dimosthenis Skarlos; Guido Hennig; Epaminondas Samantas; Dimitrios Bafaloukos; Pavlos Papakostas; Haralabos P Kalofonos; Nicholas Pavlidis; George Fountzilas
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Breast cancer research and treatment 2009;116(1):131-43.
2009: Andreas A Argyriou; Haralabos P Kalofonos
Recent advances relating to the clinical application of naked monoclonal antibodies in solid tumors.
Molecular medicine (Cambridge, Mass.) 2009;15(5-6):183-91.
2009: Efstathia Giannopoulou; Anna Antonacopoulou; Konstantina Floratou; Athanasios G Papavassiliou; Haralabos P Kalofonos
Dual targeting of EGFR and HER-2 in colon cancer cell lines.
Cancer chemotherapy and pharmacology 2009;63(6):973-81.
2009: George Fountzilas; Urania Dafni; Meletios A Dimopoulos; A Koutras; Dimosthenis Skarlos; Pavlos Papakostas; Helen Gogas; Dimitrios Bafaloukos; Anna Kalogera-Fountzila; Epaminondas Samantas; Evangelos Briasoulis; Dimitrios Pectasides; N Maniadakis; F Matsiakou; Gerasimos Aravantinos; Christos Papadimitriou; Maria Karina; Christos Christodoulou; Paris A Kosmidis; Haralabos P Kalofonos
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study.
Breast cancer research and treatment 2009;115(1):87-99.
2009: Vassiliki Tzelepi; Petros Grivas; Zinovia Kefalopoulou; Haralabos P Kalofonos; John Varakis; Maria Melachrinou; Georgia Sotiropoulou-Bonikou
Estrogen signaling in colorectal carcinoma microenvironment: expression of ERbeta1, AIB-1, and TIF-2 is upregulated in cancer-associated myofibroblasts and correlates with disease progression.
Virchows Archiv : an international journal of pathology 2009;454(4):389-99.
2009: Andreas A Argyriou; Haralabos P Kalofonos
Molecularly targeted therapies for malignant gliomas.
Molecular medicine (Cambridge, Mass.) 2009;15(3-4):115-22.
2009: Konstantinos Assimakopoulos; Katerina Karaivazoglou; Amalia A Ifanti; Miltiadis K Gerolymos; Haralabos P Kalofonos; Gregoris Iconomou
Religiosity and its relation to quality of life in Christian Orthodox cancer patients undergoing chemotherapy.
Psycho-oncology 2009;18(3):284-9.
2009: Andreas A Argyriou; Anna Antonacopoulou; Gregoris Iconomou; Haralabos P Kalofonos
Treatment options for malignant gliomas, emphasizing towards new molecularly targeted therapies.
Critical reviews in oncology/hematology 2009;69(3):199-210.
2009: Ch Gialeli; Dimitris Kletsas; D Mavroudis; Haralabos P Kalofonos; George N Tzanakakis; Nikos Karamanos
Targeting epidermal growth factor receptor in solid tumors: critical evaluation of the biological importance of therapeutic monoclonal antibodies.
Current medicinal chemistry 2009;16(29):3797-804.
2009: Andreas A Argyriou; Anna G Antonacopoulou; Chrisoula D Scopa; Anastasia Kottorou; Athina Kominea; Stavros Peroukides; Haralabos P Kalofonos
Liability of the voltage-gated sodium channel gene SCN2A R19K polymorphism to oxaliplatin-induced peripheral neuropathy.
Oncology 2009;77(3-4):254-6.
2009: Andreas A Argyriou; Efstathia Giannopoulou; Haralabos P Kalofonos
Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas.
Oncology 2009;77(1):1-11.
2009: Christos Christodoulou; Ioannis Kostopoulos; Haralabos P Kalofonos; Evangelos Lianos; Mattheos Bobos; Evangelos Briasoulis; Helen Gogas; Evangelia Razis; Dimosthenis V Skarlos; George Fountzilas
Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation.
Oncology 2009;76(4):275-85.
2008: Angelos Koutras; K T Kalogeras; Meletios A Dimopoulos; R M Wirtz; U Dafni; E Briasoulis; Dimitrios Pectasides; Helen Gogas; C Christodoulou; Gerasimos Aravantinos; G Zografos; E Timotheadou; Pavlos Papakostas; H Linardou; E Razis; Theofanis Economopoulos; Haralabos P Kalofonos; G Fountzilas
Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
British journal of cancer 2008;99(11):1775-85.
2008: Angelos K Koutras; Haralabos P Kalofonos
Myelotoxicity in cancer patients treated with chemotherapy: negative or positive prognostic factor?
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7579.
2008: Gregoris Iconomou; Angelos Koutras; K Karaivazoglou; George Kalliolias; Konstantinos Assimakopoulos; Andreas A Argyriou; A Ifanti; Haralabos P Kalofonos
Effect of epoetin alpha therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy.
European journal of cancer care 2008;17(6):535-41.
2008: Gerasimos Aravantinos; George Fountzilas; Aristotelis Bamias; Irene Grimani; Spyridon Rizos; Haralabos P Kalofonos; Dimosthenis V Skarlos; Theofanis Economopoulos; Paris A Kosmidis; George P Stathopoulos; Evangelos Briasoulis; Dimitrios Pectasides; Epaminondas Samantas; Eleni Timotheadou; Christos Papadimitriou; Alexandros Papanikolaou; Adimchi Onyenadum; Pavlos Papakostas; Dimitrios Bafaloukos; Meletios A Dimopoulos
Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
European journal of cancer (Oxford, England : 1990) 2008;44(15):2169-77.
2008: Angelos Koutras; George Fountzilas; Urania Dafni; Meletios A Dimopoulos; Dimitrios Pectasides; George Klouvas; Pavlos Papakostas; Paris A Kosmidis; Epaminondas Samantas; Helen Gogas; Evangelos Briasoulis; Georgia Vourli; Theodoros Petsas; Nikolaos Xiros; Haralabos P Kalofonos
Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology Group.
Anticancer research 2008;28(5B):2913-20.
2008: Andreas A Argyriou; Gregoris Iconomou; Haralabos P Kalofonos
Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature.
Blood 2008;112(5):1593-9.
2008: Haralabos P Kalofonos; A Bamias; A Koutras; Pavlos Papakostas; G Basdanis; E Samantas; Maria Karina; D Misailidou; N Pisanidis; George Pentheroudakis; Theofanis Economopoulos; C Papadimitriou; D V Skarlos; Dimitrios Pectasides; M Stavropoulos; Dimitrios Bafaloukos; D Kardamakis; Charisios Karanikiotis; G Vourli; G Fountzilas
A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group Study.
European journal of cancer (Oxford, England : 1990) 2008;44(12):1693-700.
2008: Andreas A Argyriou; Martin Koltzenburg; Panagiotis Polychronopoulos; Spiridon Papapetropoulos; Haralabos P Kalofonos
Peripheral nerve damage associated with administration of taxanes in patients with cancer.
Critical reviews in oncology/hematology 2008;66(3):218-28.
2008: Andreas A Argyriou; Panagiotis Polychronopoulos; Gregoris Iconomou; Elisabeth Chroni; Haralabos P Kalofonos
A review on oxaliplatin-induced peripheral nerve damage.
Cancer treatment reviews 2008;34(4):368-77.
2008: George Pentheroudakis; George Fountzilas; Haralabos P Kalofonos; Vassilios Golfinopoulos; Gerasimos Aravantinos; Dimitrios Bafaloukos; Pavlos Papakostas; Dimitrios Pectasides; Christos Christodoulou; Konstantinos Syrigos; Theofanis Economopoulos; Nicholas Pavlidis
Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Critical reviews in oncology/hematology 2008;66(3):237-47.
2008: George Fountzilas; Urania Dafni; Helen Gogas; Helena Linardou; Haralabos P Kalofonos; Evangelos Briasoulis; Dimitrios Pectasides; Epaminondas Samantas; Dimitrios Bafaloukos; George P Stathopoulos; Maria Karina; Christos Papadimitriou; Dimosthenis Skarlos; N Pisanidis; Pavlos Papakostas; Christos Markopoulos; E Tzorakoeleftherakis; K Dimitrakakis; P Makrantonakis; N Xiros; A Polichronis; I Varthalitis; Charisios Karanikiotis; Athanassios Meletios Dimopoulos
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(5):853-60.
2008: Anna G Antonacopoulou; Petros D Grivas; Lambros Skarlas; Melpomeni Kalofonos; Chrisoula D Scopa; Haralabos P Kalofonos
POLR2F, ATP6V0A1 and PRNP expression in colorectal cancer: new molecules with prognostic significance?
Anticancer research 2008;28(2B):1221-7.
2008: Angelos Koutras; Nicholas S Mastronikolis; T R Jeffry Evans; Evangelos S Papadeas; Thomas Makatsoris; Haralabos P Kalofonos
Irreversible ototoxicity associated with the use of erlotinib in a patient with pancreatic cancer.
Acta oncologica (Stockholm, Sweden) 2008;47(6):1171-3.
2008: George Pentheroudakis; Evangelos Briasoulis; Haralabos P Kalofonos; George Fountzilas; Theofanis Economopoulos; Georgios Fotios Samelis; Aris Koutras; Maria Karina; Nikolaos Xiros; Epaminondas Samantas; Aristotelis Bamias; Nicholas Pavlidis
Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study.
Acta oncologica (Stockholm, Sweden) 2008;47(6):1148-55.
2008: Paris A Kosmidis; Haralabos P Kalofonos; Christos Christodoulou; Konstantinos Syrigos; Thomas Makatsoris; Dimosthenis Skarlos; C Bakogiannis; Costas Nicolaides; Dimitrios Bafaloukos; Aristotelis Bamias; Epaminondas Samantas; Nikolaos Xiros; Ioannis Boukovinas; George Fountzilas; Meletios A Dimopoulos
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(1):115-22.
2007: Angelos Koutras; M K Gerolymos; E Kontogeorgou; Gregoris Iconomou; G Vourli; E Tsiata; Thomas Makatsoris; C Chrysanthopoulos; Haralabos P Kalofonos
Phase II study of irinotecan plus leucovorin and bolus 5-fluorouracil as first- or second-line chemotherapy in patients with advanced gastric or esophageal-gastric junction adenocarcinoma.
Journal of chemotherapy (Florence, Italy) 2007;19(6):724-30.
2007: Dimitrios Pectasides; Urania Dafni; Gerasimos Aravantinos; Eleni Timotheadou; Dimosthenis V Skarlos; N Pavlidis; Asimina Gaglia; Haralabos P Kalofonos; George Fountzilas
A randomized trial to compare the efficacy and safety of antiemetic treatment with ondansetron and ondansetron zydis in patients with breast cancer treated with high-dose epirubicin.
Anticancer research 2007;27(6C):4411-7.
2007: Angelos Koutras; Dimitrios Krikelis; Natassa Alexandrou; Ioannis Starakis; Haralabos P Kalofonos
Brain metastasis in renal cell cancer responding to sunitinib.
Anticancer research 2007;27(6C):4255-7.
2007: Adimchi Onyenadum; Helen Gogas; Christos Markopoulos; Dimitrios Bafaloukos; Gerasimos Aravantinos; Marina Mantzourani; Angelos Koutras; E Tzorakoelefterakis; Nikolaos Xiros; Thomas Makatsoris; George Fountzilas; Haralabos P Kalofonos
Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer.
Journal of chemotherapy (Florence, Italy) 2007;19(5):582-9.
2007: Athanassios C Tsamandas; Anna Antonacopoulou; Christina Kalogeropoulou; Irene Tsota; Petros Zabakis; Efstathia Giannopoulou; Anna Liava; Vassiliki Tzelepi; Konstantinos Tepetes; Theodore Petsas; Dimitrios Kardamakis; Haralabos P Kalofonos
Oval cell proliferation in cirrhosis in rats. An experimental study.
Hepatology research : the official journal of the Japan Society of Hepatology 2007;37(9):755-64.
2007: Andreas A Argyriou; Panagiotis Polychronopoulos; Angelos Koutras; Nikolaos Xiros; Theodore Petsas; Konstantinos Argyriou; Haralabos P Kalofonos; Elisabeth Chroni
Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel-based chemotherapy.
European journal of cancer care 2007;16(3):231-7.
2007: Paris A Kosmidis; Meletios A Dimopoulos; Konstantinos Syrigos; Costas Nicolaides; Gerasimos Aravantinos; Ioannis Boukovinas; Dimitrios Pectasides; George Fountzilas; Dimitrios Bafaloukos; Christos Bacoyiannis; Haralabos P Kalofonos
Gemcitabine versus gemcitabine-carboplatin for patients with advanced non-small cell lung cancer and a performance status of 2: a prospective randomized phase II study of the Hellenic Cooperative Oncology Group.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(2):135-40.
2007: Olympia Tzaida; Helen Gogas; Urania Dafni; Aspasia Kyroudi; IA Papaspyrou; Vasiliki Kyriakou; Vasiliki Malamou-Mitsi; Maria Alamani; Chrisoula Skopa; Ioannis Kostopoulos; Efstathios Kastritis; Dimitrios Pectasides; Evangelos Briasoulis; Haralabos P Kalofonos; Gerasimos Aravantinos; George Fountzilas; Petroula Arapantoni-Dadioti
Evaluation of the prognostic and predictive value of HER-1/EGFR in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
Oncology 2007;72(5-6):388-96.
2007: Thomas Makatsoris; Pavlos Papakostas; Haralabos P Kalofonos; Ioannis Xanthakis; Dimitrios Tsavdaridis; Gerasimos Aravantinos; Helen Gogas; George Klouvas; Paris A Kosmidis; Dimitrios Pectasides; George Fountzilas
Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II study.
Medical oncology (Northwood, London, England) 2007;24(3):301-7.
2007: Andreas A Argyriou; Panagiotis Polychronopoulos; Gregoris Iconomou; Angelos Koutras; Thomas Makatsoris; Miltiadis K Gerolymos; Philippos Gourzis; Konstantinos Assimakopoulos; Haralabos P Kalofonos; Elisabeth Chroni
Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer.
Acta oncologica (Stockholm, Sweden) 2007;46(8):1131-7.
2007: Christos Kosmas; Nicolas Tsavaris; Konstantinos Syrigos; Angelos Koutras; George Tsakonas; Thomas Makatsoris; Nicolas Mylonakis; Athanasios Karabelis; George P Stathopoulos; Haralabos P Kalofonos
A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens.
Cancer chemotherapy and pharmacology 2007;59(1):51-9.
2006: Andreas A Argyriou; Elisabeth Chroni; Panagiotis Polychronopoulos; Gregoris Iconomou; Angelos Koutras; Thomas Makatsoris; M K Gerolymos; Philippos Gourzis; Konstantinos Assimakopoulos; Haralabos P Kalofonos
Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy.
Neurology 2006;67(12):2253-5.
2006: V T Labropoulou; Achilleas D Theocharis; Panagiota Ravazoula; Petros Perimenis; Anders Hjerpe; Nikos Karamanos; Haralabos P Kalofonos
Versican but not decorin accumulation is related to metastatic potential and neovascularization in testicular germ cell tumours.
Histopathology 2006;49(6):582-93.
2006: Filitsa A Badra; Michalis V Karamouzis; Panagiota Ravazoula; Eleni Likaki-Karatza; Evagelos Tzorakoleftherakis; Dimitrios Koukouras; Gregoris Iconomou; Nikolaos Xiros; Dimitrios Siablis; Athanasios G Papavassiliou; Haralabos P Kalofonos
Non-palpable breast carcinomas: correlation of mammographically detected malignant-appearing microcalcifications and epidermal growth factor receptor (EGFR) family expression.
Cancer letters 2006;244(1):34-41.
2006: Andreas A Argyriou; Elisabeth Chroni; Angelos Koutras; Gregoris Iconomou; Spiridon Papapetropoulos; Panagiotis Polychronopoulos; Haralabos P Kalofonos
A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2006;14(11):1134-40.
2006: Andreas A Argyriou; Elisabeth Chroni; Angelos Koutras; Gregoris Iconomou; Spiridon Papapetropoulos; Panagiotis Polychronopoulos; Haralabos P Kalofonos
Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation.
Journal of pain and symptom management 2006;32(3):237-44.
2006: Davide Mauri; George Pentheroudakis; Dimitrios Bafaloukos; Dimitrios Pectasides; Epaminondas Samantas; Eleni Efstathiou; Haralabos P Kalofonos; Konstantinos Syrigos; George Klouvas; Pavlos Papakostas; Paris A Kosmidis; George Fountzilas; Nicholas Pavlidis
Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.
Anticancer research 2006;26(4B):3175-81.
2006: George Pentheroudakis; George Fountzilas; Dimitrios Bafaloukos; Vasiliki Koutsoukou; Dimitrios Pectasides; Dimosthenis Skarlos; Epaminondas Samantas; Haralabos P Kalofonos; Helen Gogas; Nicholas Pavlidis
Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
Breast cancer research and treatment 2006;97(3):237-44.
2006: Angelos Koutras; Ioannis Habeos; Apostolos G Vagenakis; Haralabos P Kalofonos
Capecitabine-induced hypertriglyceridemia: a report of two cases.
Anticancer research 2006;26(3B):2249-51.
2006: Adimchi Onyenadum; Helen Gogas; Paris A Kosmidis; Gerasimos Aravantinos; Dimitrios Bafaloukos; H Bacoyiannis; Christos Markopoulos; Angelos Koutras; E Tzorakoelefterakis; Thomas Makatsoris; George Fountzilas; Haralabos P Kalofonos
Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancer.
Journal of chemotherapy (Florence, Italy) 2006;18(2):192-8.
2006: Gregoris Iconomou; Haralabos P Kalofonos; Angelos Koutras; Apostolos G Vagenakis; Basil Rigas
Pilot study of nitric oxide-donating aspirin in patients with pancreatic cancer pain.
The journal of supportive oncology 2006;4(4):168.
2006: Helen P Kourea; Angelos Koutras; Vassiliki Zolota; Irene Grimani; Evangelos Tzoracoeleftherakis; Dimitrios Koukouras; George Fountzilas; Helen Gogas; Kyriakos Kyriakou; Adamos Adamou; Haralabos P Kalofonos
Expression of p27KIP1, p21WAF1 and p53 does not correlate with prognosis in node-negative invasive ductal carcinoma of the breast.
Anticancer research 2006;26(2B):1657-68.
2006: Michalis V Karamouzis; Amalia A Ifanti; Gregoris Iconomou; Apostolos G Vagenakis; Haralabos P Kalofonos
Medical students' views of undergraduate Oncology education: A comparative study.
Education for health (Abingdon, England) 2006;19(1):61-70.
2006: Gregoris Iconomou; Anna Viha; Angelos Koutras; I Koukourikou; V Mega; Thomas Makatsoris; Adimchi Onyenadum; Konstantinos Assimakopoulos; Apostolos G Vagenakis; Haralabos P Kalofonos
Impact of providing booklets about chemotherapy to newly presenting patients with cancer: a randomized controlled trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(3):515-20.
2006: Andreas A Argyriou; Panagiotis Polychronopoulos; Angelos Koutras; Gregoris Iconomou; Philippos Gourzis; Konstantinos Assimakopoulos; Haralabos P Kalofonos; Elisabeth Chroni
Is advanced age associated with increased incidence and severity of chemotherapy-induced peripheral neuropathy?
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2006;14(3):223-9.
2006: Aristotelis Bamias; Lia A Moulopoulos; Angelos Koutras; Gerasimos Aravantinos; George Fountzilas; Dimitrios Pectasides; Efstathios Kastritis; Dimitra Gika; Dimosthenis Skarlos; Helena Linardou; Haralabos P Kalofonos; Meletios A Dimopoulos
The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.
Cancer 2006;106(2):297-303.
2006: Haralabos P Kalofonos; Petros D Grivas
Monoclonal antibodies in the management of solid tumors.
Current topics in medicinal chemistry 2006;6(16):1687-705.
2006: Stelios Assimakopoulos; Angelos Koutras; Panagiota Ravazoula; Thomas Makatsoris; Theodore Petsas; Gregoris Iconomou; Vassiliki N Nikolopoulou; Haralabos P Kalofonos
A case of chondrosarcoma developing in a recurrent retroperitoneal mass after chemotherapy for testicular germ cell tumor.
Urologia internationalis 2006;77(1):86-8.
2006: Pavlos Papakostas; Dimitrios Tsavdaridis; Paris Kosmidis; Haralabos P Kalofonos; Athanassios Sakantamis; Dimitrios Janinis; Dimosthenis Skarlos; Dimitrios Bafaloukos; Aristotelis Bamias; Nikolaos Xiros; George Fountzilas
Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2006;9(1):26-31.
2006: Christos Christodoulou; Haralabos P Kalofonos; Evangelos Briasoulis; Dimitrios Bafaloukos; Thomas Makatsoris; Angelos Koutras; Dimosthenis V Skarlos; Epaminondas Samantas
Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG).
Cancer chemotherapy and pharmacology 2006;57(2):207-12.
2005: Andreas A Argyriou; Panagiotis Polychronopoulos; Gregoris Iconomou; Angelos Koutras; Haralabos P Kalofonos; Elisabeth Chroni
Paclitaxel plus carboplatin-induced peripheral neuropathy. A prospective clinical and electrophysiological study in patients suffering from solid malignancies.
Journal of neurology 2005;252(12):1459-64.
2005: Andreas A Argyriou; Angelos Koutras; Panagiotis Polychronopoulos; Spiridon Papapetropoulos; Gregoris Iconomou; George Katsoulas; Thomas Makatsoris; Haralabos P Kalofonos; Elisabeth Chroni
The impact of paclitaxel or cisplatin-based chemotherapy on sympathetic skin response: a prospective study.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2005;12(11):858-61.
2005: George Fountzilas; Dimosthenis Skarlos; Urania Dafni; Helen Gogas; Evangelos Briasoulis; Dimitrios Pectasides; Christos Papadimitriou; Christos Markopoulos; A Polychronis; Haralabos P Kalofonos; V Siafaka; Paris A Kosmidis; Eleni Timotheadou; Dimitrios Tsavdaridis; Dimitrios Bafaloukos; Pavlos Papakostas; Evangelia Razis; P Makrantonakis; Gerasimos Aravantinos; Christos Christodoulou; Athanassios Meletios Dimopoulos
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(11):1762-71.
2005: Andreas A Argyriou; Panagiotis Polychronopoulos; Angelos Koutras; Gregoris Iconomou; Alexander Iconomou; Haralabos P Kalofonos; Elisabeth Chroni
Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted?
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2005;13(8):647-51.
2005: Dimosthenis V Skarlos; Haralabos P Kalofonos; George Fountzilas; Meletios A Dimopoulos; Nicholas Pavlidis; Evangelia Razis; Theofanis Economopoulos; Dimitrios Pectasides; Helen Gogas; Paris A Kosmidis; Dimitrios Bafaloukos; George Klouvas; George Kyratzis; Gerasimos Aravantinos
Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study.
Anticancer research 2005;25(4):3103-8.
2005: George Fountzilas; Dimitrios Pectasides; Anna Kalogera-Fountzila; Dimosthenis Skarlos; Haralabos P Kalofonos; Christos Papadimitriou; Dimitrios Bafaloukos; Stefanos Lambropoulos; Savvas Papadopoulos; Helen P Kourea; Christos Markopoulos; Helena Linardou; Dimitrios Mavroudis; Evangelos Briasoulis; Nicholas Pavlidis; Evangelia Razis; Paris A Kosmidis; Helen Gogas
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group.
Breast cancer research and treatment 2005;92(1):1-9.
2005: Gerasimos Aravantinos; George Fountzilas; Paris A Kosmidis; Meletios A Dimopoulos; George P Stathopoulos; Nicholas Pavlidis; Dimitrios Bafaloukos; Christos Papadimitriou; S Karpathios; Vassilis Georgoulias; Pavlos Papakostas; Haralabos P Kalofonos; E Grimani; Dimosthenis V Skarlos
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1116-22.
2005: Haralabos P Kalofonos; Gerasimos Aravantinos; Paris A Kosmidis; Pavlos Papakostas; Theofanis Economopoulos; Meletios A Dimopoulos; Dimosthenis Skarlos; Aristotelis Bamias; Dimitrios Pectasides; S Chalkidou; Maria Karina; Angelos Koutras; Epaminondas Samantas; Christos Bacoyiannis; Georgios Fotios Samelis; George Basdanis; Fotis Kalfarentzos; George Fountzilas
Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(6):869-77.
2005: Dimitrios Pectasides; George Fountzilas; Gerasimos Aravantinos; Haralabos P Kalofonos; Eleni Efstathiou; Emmanuel Salamalekis; Dimitrios Farmakis; Dimosthenis Skarlos; Evangelos Briasoulis; Theofanis Economopoulos; Meletios A Dimopoulos
Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
Gynecologic oncology 2005;97(2):436-41.
2005: Andreas A Argyriou; Elisabeth Chroni; Angelos Koutras; John Ellul; Spiridon Papapetropoulos; George Katsoulas; Gregoris Iconomou; Haralabos P Kalofonos
Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial.
Neurology 2005;64(1):26-31.
2005: Christos Kosmas; Nicolas Tsavaris; Angelos Koutras; Thomas Makatsoris; Nicolas Mylonakis; George Tzelepis; Antonios Dimitrakopoulos; Konstantinos Spyropoulos; Aristidis Polyzos; Athanasios Karabelis; Haralabos P Kalofonos
A phase II study of the docetaxel-ifosfamide-carboplatin combination in advanced non-small-cell lung cancer.
Oncology 2005;69(4):333-41.
2005: Thomas Makatsoris; Haralabos P Kalofonos; Gerasimos Aravantinos; Christos Papadimitriou; Efstathios Kastritis; Sotiris K Rigatos; Nikolaos Xiros; Theodore Petsas; Theofanis Economopoulos; Athanassios K Sakadamis; George Fountzilas
A phase II study of capecitabine plus oxaliplatin (XELOX): a new first-line option in metastatic colorectal cancer.
International journal of gastrointestinal cancer 2005;35(2):103-9.
2004: George Fountzilas; Haralabos P Kalofonos; Urania Dafni; Christos Papadimitriou; Dimitrios Bafaloukos; Pavlos Papakostas; Anna Kalogera-Fountzila; Helen Gogas; Gerasimos Aravantinos; Lia A Moulopoulos; Theofanis Economopoulos; Dimitrios Pectasides; N Maniadakis; V Siafaka; Evangelos Briasoulis; Christos Christodoulou; Dimitrios Tsavdaridis; P Makrantonakis; Evangelia Razis; Paris A Kosmidis; Dimosthenis Skarlos; Meletios A Dimopoulos
Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(10):1517-26.
2004: Dimitrios Bafaloukos; Dimosthenis A Tsoutsos; George Fountzilas; Helena Linardou; Christos Christodoulou; Haralabos P Kalofonos; Evangelos Briassoulis; Petros Panagiotou; Helen Hatzichristou; Helen Gogas
The effect of temozolomide-based chemotherapy in patients with cerebral metastases from melanoma.
Melanoma research 2004;14(4):289-94.
2004: Gregoris Iconomou; Vasiliki Mega; Angelos Koutras; Alexander V Iconomou; Haralabos P Kalofonos
Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy.
Cancer 2004;101(2):404-11.
2004: Haralabos P Kalofonos; Dimitrios Bafaloukos; Theodoros G Kourelis; Michalis V Karamouzis; Panagiotis Megas; Gregoris Iconomou; Ekaterini Tsiata; Dimitrios Dimitropoulos; Paris A Kosmidis; E Lampiris
Adriamycin and cis-platinum as first-line treatment in unresectable locally advanced or metastatic adult soft-tissue sarcomas.
American journal of clinical oncology 2004;27(3):307-11.
2004: Jim Janinis; George P Stathopoulos; Pavlos Nikolaidis; Haralabos P Kalofonos; Anna Kalogera-Fountzila; Epaminondas Samantas; Gerasimos Aravantinos; Athanassios Anagnostopoulos; Christos Tolis; Thomas Makatsoris; Sotiris K Rigatos; Dimitrios Bafaloukos; Meletios A Dimopoulos; John Daniilidis; George Fountzilas
Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).
Anti-cancer drugs 2004;15(5):479-87.
2004: Helen Gogas; Dimitrios Bafaloukos; John Ioannovich; Dimosthenis Skarlos; Aristidis Polyzos; George Fountzilas; Haralabos P Kalofonos; Gerasimos Aravantinos; Dimosthenis A Tsoutsos; Petros Panagiotou; Konstantina Frangia; Theodora Petrakopoulou; Dimitrios Pectasides
Tolerability of adjuvant high-dose interferon alfa-2b: 1 month versus 1 year--a Hellenic Cooperative Oncology Group study.
Anticancer research 2004;24(3b):1947-52.
2004: Athanassios C Tsamandas; Dimitrios Kardamakis; Panagiota Ravazoula; Vassiliki Zolota; Stavroula Salakou; Konstantinos Tepetes; Christina Kalogeropoulou; Irene Tsota; Theodore Kourelis; Thomas Makatsoris; Dionissios Karavias; Chrisoula D Scopa; Dionysis S Bonikos; Haralabos P Kalofonos; Theodore Petsas
The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2004;180(4):201-8.
2004: George Fountzilas; George P Stathopoulos; George Kouvatseas; A Polychronis; George Klouvas; Epaminondas Samantas; Nikolaos Zamboglou; K Kyriakou; Adamos Adamou; D Pectasidis; Th Ekonomopoulos; Haralabos P Kalofonos; Dimitrios Bafaloukos; Vassilis Georgoulias; Evangelia Razis; Dimitrios Koukouras; V Zombolas; Paris A Kosmidis; Dimosthenis Skarlos; Nicholas Pavlidis
Adjuvant cytotoxic and endocrine therapy in pre- and postmenopausal patients with breast cancer and one to nine infiltrated nodes: five-year results of the Hellenic Cooperative Oncology Group randomized HE 10/92 study.
American journal of clinical oncology 2004;27(1):57-67.
2004: Haralabos P Kalofonos; Charalabos Kourousis; Michalis V Karamouzis; Gregoris Iconomou; Ekaterini Tsiata; Fotis Tzorzidis; Panagiotis Megas; Elias Lambiris; Vasilios Georgoulias
A Phase II Study of Docetaxel and Epirubicin in Advanced Adult Soft Tissue Sarcomas (STS).
Sarcoma 2004;8(4):129-33.
2004: Helen Gogas; Dimitrios Bafaloukos; Gerasimos Aravantinos; George Fountzilas; Dimosthenis A Tsoutsos; Petros Panagiotou; Konstantina Frangia; Haralabos P Kalofonos; E Briasoulis; Ourania Castana; Aristidis Polyzos; Dimitrios Pectasides; John Ioannovich
Vinorelbine in combination with interleukin-2 as second-line treatment in patients with metastatic melanoma. A phase II study of the Hellenic Cooperative Oncology Group.
Cancer investigation 2004;22(6):832-9.
2004: George Fountzilas; Christos Christodoulou; Dimitrios Tsavdaridis; Anna Kalogera-Fountzila; Gerasimos Aravantinos; Evangelia Razis; Haralabos P Kalofonos; Pavlos Papakostas; Maria Karina; Helen Gogas; Dimosthenis Skarlos
Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).
Cancer investigation 2004;22(5):655-62.
2004: Angelos Koutras; Thomas Makatsoris; Fotini Paliogianni; G Kopsida; Adimchi Onyenadum; Charalambos Gogos; Athanasia Mouzaki; Haralabos P Kalofonos
Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis.
Oncology 2004;67(2):179-82.
2003: Helen P Kourea; Angelos Koutras; Chrisoula D Scopa; Markos Marangos; Evangelos Tzoracoeleftherakis; Dimitrios Koukouras; Haralabos P Kalofonos
Expression of the cell cycle regulatory proteins p34cdc2, p21waf1, and p53 in node negative invasive ductal breast carcinoma.
Molecular pathology : MP 2003;56(6):328-35.
2003: S Sofroniadou; Christos Kosmas; Theodore Kourelis; Thomas Makatsoris; Angelos Koutras; A Onienadoum; Haralabos P Kalofonos
Absence of chemotherapy-induced alopecia with paclitaxel in a case of hypothyroidism: case report.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(11):1690-1.
2003: Chrisoula D Scopa; Athanassios C Tsamandas; Vassiliki Zolota; Haralabos P Kalofonos; Anna Batistatou; Constantine E Vagianos
Potential role of bcl-2 and ki-67 expression and apoptosis in colorectal carcinoma: a clinicopathologic study.
Digestive diseases and sciences 2003;48(10):1990-7.
2003: Gregoris Iconomou; Angelos Koutras; Antonis Rigopoulos; Apostolos G Vagenakis; Haralabos P Kalofonos
Effect of recombinant human erythropoietin on quality of life in cancer patients receiving chemotherapy: results of a randomized, controlled trial.
Journal of pain and symptom management 2003;25(6):512-8.
2003: Angelos Koutras; Markos Marangos; Theodoros Kourelis; Melpomeni Partheni; Dimitrios Dougenis; Gregoris Iconomou; Apostolos G Vagenakis; Haralabos P Kalofonos
Surgical management of cerebral metastases from non-small cell lung cancer.
Tumori 2003;89(3):292-7.
2003: Theoni N Mitropoulou; George N Tzanakakis; Dimitris Kletsas; Haralabos P Kalofonos; Nikos Karamanos
Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells.
International journal of cancer. Journal international du cancer 2003;104(2):155-60.
2003: Haralabos P Kalofonos; Dimitrios Kardamakis; Aristotelis Bamias; Dimosthenis Skarlos; Pavlos Papakostas; Dimitrios Bafaloukos; Athanasios Sakantamis; Nicolas Pavlidis; George Fountzilas
Adjuvant chemotherapy using CPT-11, leucovorin plus bolus 5-fluorouracil and radiotherapy in patients with rectal cancer. A feasibility study.
Anticancer research 2003;23(2C):1687-91.
2003: Christos Kosmas; Nicolas Tsavaris; Nicolas Mylonakis; Haralabos P Kalofonos
An overview of current results with the gemcitabine and docetaxel combination as initial and salvage chemotherapy regimen in advanced non-small cell lung cancer.
Critical reviews in oncology/hematology 2003;45(3):265-75.
2003: Haralabos P Kalofonos; Dimosthenis Skarlos; Dimitrios Bafaloukos; Pavlos Papakostas; Aristotelis Bamias; Jim Janinis; Eleni Timotheadou; George Kouvatseas; M Stavropoulos; T Economopulos; George Fountzilas
A phase II study with CPT-11 plus leucovorin and bolus IV 5-fluorouracil in patients with advanced colorectal carcinoma.
Cancer investigation 2003;21(6):855-62.
2002: Helen Gogas; George Paterakis; Konstantina Frangia; Dimitrios Bafaloukos; Dimitrios Pectasides; Haralabos P Kalofonos; Dimitris Loukopoulos; Cathrin Stavropoulou-Giokas; John Ioannovich; Martin C Mihm
Lymphocyte subpopulations and interleukin levels in high-risk melanoma patients treated with high-dose interferon A-2B.
American journal of clinical oncology 2002;25(6):591-6.
2002: C Christodolou; Nicholas Pavlidis; Epaminondas Samantas; George Fountzilas; George Kouvatseas; K Pagdatoglou; F Palamidas; C Nikolaidis; M Angelidou; Haralabos P Kalofonos; Paris A Kosmidis; Dimosthenis V Skarlos
Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study.
Anticancer research 2002;22(6B):3749-57.
2002: Dimitrios Pectasides; George Fountzilas; A Rigopoulos; NG Bountouroglou; Angelos Koutras; J Glotsos; Adimchi Onyenadum; Thomas Makatsoris; Haralabos P Kalofonos
Irinotecan and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. A phase II study of the Hellenic Cooperative Oncology Group.
Anticancer research 2002;22(6B):3501-6.
2002: Helen Gogas; Christos Papadimitriou; Haralabos P Kalofonos; Dimitrios Bafaloukos; George Fountzilas; Dimitrios Tsavdaridis; Athanasios Anagnostopoulos; Adimchi Onyenadum; Pavlos Papakostas; Theofanis Economopoulos; Christos Christodoulou; Paris A Kosmidis; Christos Markopoulos
Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(11):1737-42.
2002: Michalis V Karamouzis; Eleni Likaki-Karatza; Panagiota Ravazoula; Filitsa A Badra; Dimitrios Koukouras; Evagelos Tzorakoleftherakis; Athanasios G Papavassiliou; Haralabos P Kalofonos
Non-palpable breast carcinomas: correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors.
International journal of cancer. Journal international du cancer 2002;102(1):86-90.
2002: Gregoris Iconomou; Anna Viha; Angelos Koutras; Apostolos G Vagenakis; Haralabos P Kalofonos
Information needs and awareness of diagnosis in patients with cancer receiving chemotherapy: a report from Greece.
Palliative medicine 2002;16(4):315-21.
2002: Christos Kosmas; Nicolas Tsavaris; Haralabos P Kalofonos
Salvage chemotherapy with the gemcitabine/docetaxel combination in non-small cell lung cancer: an overview of recent phase II studies.
Medical science monitor : international medical journal of experimental and clinical research 2002;8(6):PI58-63.
2002: Christos Kosmas; Nicolas Tsavaris; Thomas Makatsoris; Adimchi Onyenadum; Maria Vadiaka; Niki Stavroyianni; Evangelos Sepsas; Dimitris Dimitropoulos; Sofia Rokana; Haralabos P Kalofonos
A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer.
International journal of cancer. Journal international du cancer 2002;98(1):141-7.
2002: Spyridon Voulgaris; Melpomeni Partheni; Michalis V Karamouzis; Panayiotis Dimopoulos; Nikolas Papadakis; Haralabos P Kalofonos
Intratumoral doxorubicin in patients with malignant brain gliomas.
American journal of clinical oncology 2002;25(1):60-4.
2002: Haralabos P Kalofonos; Costas Nicolaides; Epaminondas Samantas; Nicolas Mylonakis; Gerasimos Aravantinos; Meletios A Dimopoulos; Constantinos Gennatas; George Kouvatseas; Eleftherios Giannoulis; Christos Dervenis; George Basdanis; Nicholas Pavlidis; Ioannis Androulakis; George Fountzilas
A phase III study of 5-fluorouracil versus 5-fluorouracil plus interferon alpha 2b versus 5-fluorouracil plus leucovorin in patients with advanced colorectal cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
American journal of clinical oncology 2002;25(1):23-30.
2002: Christos Bacoyiannis; Meletios A Dimopoulos; Haralabos P Kalofonos; Costas Nicolaides; Gerasimos Aravantinos; Dimitrios Bafaloukos; Georgios Fotios Samelis; Adimchi Onyenadum; Christos Kiamouris; Dimosthenis Skarlos; Nicholas Pavlidis; A Triantafillidis; Paris A Kosmidis
Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trials.
Oncology 2002;63(2):130-8.
2001: Chrisoula D Scopa; Constantine E Vagianos; Dimitrios Kardamakis; Theodore Kourelis; Haralabos P Kalofonos; Athanassios C Tsamandas
bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2001;9(4):329-34.
2001: Christos Kosmas; Nicolas Tsavaris; Maria Vadiaka; Niki Stavroyianni; Angelos Koutras; Nikolaos Malamos; Adimchi Onyenadum; Sofia Rokana; Aristidis Polyzos; Haralabos P Kalofonos
Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.
Cancer 2001;92(11):2902-10.
2001: Haralabos P Kalofonos; Adimchi Onyenadum; Christos Kosmas; Angelos Koutras; Theodore Petsas; V Efthimiou; Dimitrios Koukouras; E Tzoracolefterakis; P Andrikopoulos; John Androulakis
Mitomycin C and vinblastine in anthracycline-resistant metastatic breast cancer: a phase II study.
Tumori 2001;87(6):394-7.
2001: Gregoris Iconomou; Apostolos G Vagenakis; Haralabos P Kalofonos
The informational needs, satisfaction with communication, and psychological status of primary caregivers of cancer patients receiving chemotherapy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2001;9(8):591-6.
2001: Dimosthenis V Skarlos; Epaminondas Samantas; Evangelos Briassoulis; E Panoussaki; Nicholas Pavlidis; Haralabos P Kalofonos; D Kardamakis; E Tsiakopoulos; Paris A Kosmidis; Dimitrios Tsavdaridis; John Tzitzikas; Pericles G Tsekeris; George Kouvatseas; Nikolaos Zamboglou; George Fountzilas
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(9):1231-8.
2001: Dimitrios Pectasides; Haralabos P Kalofonos; Epaminondas Samantas; Costas Nicolaides; P Papacostas; Adimchi Onyenadum; A Visvikis; Dimosthenis Skarlos; George Fountzilas
An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.
Anticancer research 2001;21(4B):3005-10.
2001: Christos Kosmas; Nicolas Tsavaris; Christos Panopoulos; Maria Vadiaka; Niki Stavroyianni; Theodore Kourelis; Nikolaos Malamos; Minas J Antonopoulos; Haralabos P Kalofonos
Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens.
European journal of cancer (Oxford, England : 1990) 2001;37(8):972-8.
2001: George Fountzilas; Christos Papadimitriou; Urania Dafni; Dimitrios Bafaloukos; Dimosthenis Skarlos; Lia A Moulopoulos; Evangelia Razis; Haralabos P Kalofonos; Gerasimos Aravantinos; Evangelos Briassoulis; Pavlos Papakostas; K Abela; E Gogas; Paris A Kosmidis; Nicholas Pavlidis; Meletios A Dimopoulos
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2232-9.
2001: Gregoris Iconomou; Anna Viha; Haralabos P Kalofonos; D Kardamakis
Impact of cancer on primary caregivers of patients receiving radiation therapy.
Acta oncologica (Stockholm, Sweden) 2001;40(6):766-71.
2001: Haralabos P Kalofonos; M V Karamouzis; Agamemnon A Epenetos
Radioimmunoscintigraphy in patients with ovarian cancer.
Acta oncologica (Stockholm, Sweden) 2001;40(5):549-57.
2000: Gregoris Iconomou; Anna Viha; Apostolos G Vagenakis; Haralabos P Kalofonos
Transdermal fentanyl in cancer patients with moderate-to-severe pain: a prospective examination.
Anticancer research 2000;20(6C):4821-4.
2000: Christos Kosmas; Nicolas Tsavaris; Aristidis Polyzos; Haralabos P Kalofonos; Evangelos Sepsas; Nikolaos Malamos; Maria Vadiaka; Theodosios Dosios; Minas J Antonopoulos
A phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma.
Cancer 2000;89(4):774-82.
2000: Costas Giannakenas; Haralabos P Kalofonos; Dimitris J Apostolopoulos; J Zarakovitis; Christos Kosmas; Pavlos Vassilakos
Preliminary results of the use of Re-186-HEDP for palliation of pain in patients with metastatic bone disease.
American journal of clinical oncology 2000;23(1):83-8.
2000: Costas Giannakenas; Haralabos P Kalofonos; Dimitris J Apostolopoulos; Theodore Petsas; Christina Kalogeropoulou; E Tzorakelefterakis; C D Skopa; Pavlos Vassilakos
Scintigraphic imaging of sarcomatous tumors with [(111)In-DTPA-phe-1]-octreotide.
Oncology 2000;58(1):18-24.
1999: Haralabos P Kalofonos; Costas Giannakenas; Christos Kosmas; Dimitris J Apostolopoulos; A Onienadum; Theodore Petsas; D Dimopoulos; Agamemnon A Epenetos; Pavlos Vassilakos
Radioimmunoscintigraphy in patients with ovarian cancer.
Acta oncologica (Stockholm, Sweden) 1999;38(5):629-34.
1998: Christos Kosmas; Haralabos P Kalofonos; V Hird; Agamemnon A Epenetos
Monoclonal antibody targeting of ovarian carcinoma.
Oncology 1998;55(5):435-46.
1994: Haralabos P Kalofonos; Christos Kosmas; V Hird; D E Snook; Agamemnon A Epenetos
Targeting of tumours with murine and reshaped human monoclonal antibodies against placental alkaline phosphatase: immunolocalisation, pharmacokinetics and immune response.
European journal of cancer (Oxford, England : 1990) 1994;30A(12):1842-50.
1990: Haralabos P Kalofonos; Mary Rusckowski; D A Siebecker; G B Sivolapenko; D Snook; J P Lavender; Agamemnon A Epenetos; Donald J Hnatowich
Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(11):1791-6.
1990: Haralabos P Kalofonos; Christos Kosmas; T R Pawlikowska; A Bamias; D Snook; B Dhokia; G B Sivolapenko; N S Courtenay-Luck; Agamemnon A Epenetos
Immunolocalisation of testicular tumours using radiolabelled monoclonal antibody to placental alkaline phosphatase.
The Journal of nuclear medicine and allied sciences 1990;34(4):294-8.
1990: Haralabos P Kalofonos; G Rowlinson; Agamemnon A Epenetos
Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation.
Cancer research 1990;50(1):159-63.
1990: Christos Kosmas; Haralabos P Kalofonos; Agamemnon A Epenetos
Radiolabelled monoclonal antibodies in tumour diagnosis and therapy.
Developments in biological standardization 1990;71():93-102.
1989: Christos Kosmas; Haralabos P Kalofonos; Agamemnon A Epenetos
Monoclonal antibodies. Future potential in cancer chemotherapy.
Drugs 1989;38(5):645-57.
1989: Haralabos P Kalofonos; T R Pawlikowska; A Hemingway; N Courtenay-Luck; B Dhokia; D Snook; G B Sivolapenko; G R Hooker; C G McKenzie; P J Lavender
Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(10):1636-45.
1989: Haralabos P Kalofonos; J M Sackier; M Hatzistylianou; S Pervez; J Taylor-Papadimitriou; J H Waxman; J P Lavender; C Wood; Agamemnon A Epenetos
Kinetics, quantitative analysis and radioimmunolocalization using indium-111-HMFG1 monoclonal antibody in patients with breast cancer.
British journal of cancer 1989;59(6):939-42.
1989: vassileios barbounis; Haralabos P Kalofonos; A J Munro; C G McKenzie; J M Sackier; Agamemnon A Epenetos
Treatment of colorectal cancer and other malignancies with continuous infusion of 5-fluorouracil.
Anticancer research 1989;9(1):33-9.
1988: C Wilson; D Pickering; S Stewart; K Vallis; Haralabos P Kalofonos; A Cross; D Snook; J M Goldman; C G McKenzie; Agamemnon A Epenetos
High dose chemotherapy with autologous bone marrow rescue in small cell lung cancer.
In vivo (Athens, Greece) 1988;2(5):331-4.
1988: Haralabos P Kalofonos; G B Sivolapenko; N S Courtenay-Luck; D E Snook; G R Hooker; R Winter; C G McKenzie; J J Taylor-Papadimitriou; P J Lavender; Agamemnon A Epenetos
Antibody guided targeting of non-small cell lung cancer using 111In-labeled HMFG1 F(ab')2 fragments.
Cancer research 1988;48(7):1977-84.
1988: Haralabos P Kalofonos; S Stewart; Agamemnon A Epenetos
Antibody-guided diagnosis and therapy of malignant lesions.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1988;2():74-80.